GT Biopharma (GTBP) | March 2017 | 5,888,081.82% |
OLB (OLB) | March 2017 | 200% |
Lixte Biotechnology (LIXT) | March 2017 | 177.78% |
TSS, Inc Common Stock (TSSI) | March 2017 | 120% |
LifeMD (LFMD) | March 2017 | 108.33% |
TG Therapeutics (TGTX) | March 2017 | 104.39% |
Opus Genetics (IRD) | March 2017 | 104% |
Aurinia Pharmaceuticals (AUPH) | March 2017 | 102.2% |
Sobr Safe (SOBR) | March 2017 | 87.5% |
Castellum (CTM) | March 2017 | 83.64% |
Power Solutions International, Inc Common Stock (PSIX) | March 2017 | 83.45% |
Verastem (VSTM) | March 2017 | 80% |
Clearpoint Neuro (CLPT) | March 2017 | 79.86% |
GrabAGun Digital (PEW) | March 2017 | 76.92% |
Catalyst Pharmaceuticals (CPRX) | March 2017 | 75.68% |
Nektar Therapeutics (NKTR) | March 2017 | 75.67% |
Harrow Health (HROW) | March 2017 | 72.31% |
Akari Therapeutics (AKTX) | March 2017 | 66.72% |
Sow Good Inc Common Stock (SOWG) | March 2017 | 66.67% |
Oncolytics Biotech (ONCY) | March 2017 | 61.25% |
Cassava Sciences (SAVA) | March 2017 | 56.14% |
Filana Therapeutics (FLNA) | March 2017 | 56.14% |
Eterna Therapeutics (ERNA) | March 2017 | 55.8% |
VerifyMe (VRME) | March 2017 | 54.84% |
HUTCHMED DRC (HCM) | March 2017 | 53.46% |
